← FDA DRUG APPROVALS

FDA ANDA · ANDA077322

ZOLPIDEM TARTRATE

Sponsor: SANDOZ

APPLICATION
ANDA077322
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-23
LATEST ACTION
2022-09-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 10MG · TABLET · ORAL
ZOLPIDEM TARTRATEPrescription
ZOLPIDEM TARTRATE 5MG · TABLET · ORAL

Approval history

2022-09-28Labeling · Supplement 20 · standardAP
2019-11-19Labeling · Supplement 17 · standardAP
2019-11-19Labeling · Supplement 15 · standardAP
2019-11-19Labeling · Supplement 18 · standardAP
2019-11-19Labeling · Supplement 16 · standardAP
2015-03-19Labeling · Supplement 14 · standardAP
2013-09-04Labeling · Supplement 12 · standardAP
2010-11-30Labeling · Supplement 9AP
2009-03-10Labeling · Supplement 6AP
2008-05-23Labeling · Supplement 2AP
2008-05-13Labeling · Supplement 5AP
2007-04-23OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →